Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study)
暂无分享,去创建一个
L. Calza | M. Re | P. Viale | M. Borderi | I. Bon | L. Bussini | V. Colangeli | E. Magistrelli